Gyeong Hoon Kang Selected Research

Proteins (Proteins, Gene)

12/2021	NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
9/2017	Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
1/2017	Downregulation of acetyl-CoA synthetase 2 is a metabolic hallmark of tumor progression and aggressiveness in colorectal carcinoma.
4/2014	RNA editing in RHOQ promotes invasion potential in colorectal cancer.
5/2013	cAMP signalling decreases p300 protein levels by promoting its ubiquitin/proteasome dependent degradation via Epac and p38 MAPK in lung cancer cells.
1/2012	Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms.
8/2009	Differential protein immunoexpression profiles in appendiceal mucinous neoplasms: a special reference to classification and predictive factors.
10/2008	STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination.
5/2008	Helicobacter pylori-infection-associated CpG island hypermethylation in the stomach and its possible association with polycomb repressive marks.
10/2007	Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gyeong Hoon Kang Research Topics

Disease

77	Neoplasms (Cancer) 03/2024 - 02/2002
61	Colorectal Neoplasms (Colorectal Cancer) 07/2023 - 02/2002
30	Microsatellite Instability 01/2023 - 02/2002
15	Stomach Neoplasms (Stomach Cancer) 01/2019 - 06/2002
14	Adenoma (Adenomas) 12/2021 - 04/2003
10	Carcinogenesis 12/2021 - 07/2004
8	Colonic Neoplasms (Colon Cancer) 01/2023 - 04/2013
8	Rectal Neoplasms (Rectal Cancer) 01/2021 - 08/2011
8	Carcinoma (Carcinomatosis) 05/2015 - 07/2003
7	Adenocarcinoma 03/2024 - 12/2003
7	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2012
6	Hepatocellular Carcinoma (Hepatoma) 12/2014 - 12/2003
5	Polyps 12/2021 - 12/2014
4	Cholangiocarcinoma 08/2017 - 09/2002
4	Lymphatic Metastasis 01/2015 - 06/2002
4	Gastritis 06/2010 - 04/2003
3	Infections 01/2017 - 05/2008
3	Body Weight (Weight, Body) 10/2015 - 11/2010
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2012 - 08/2009
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2007 - 01/2005
2	Hepatomegaly 01/2023 - 12/2017
2	Colitis 01/2023 - 01/2020
2	Neonatal hemochromatosis 03/2020 - 06/2016
2	Margins of Excision 07/2019 - 12/2013
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2018 - 09/2017
2	Necrosis 05/2017 - 09/2015
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 03/2016 - 08/2014
2	Hyperplasia 06/2015 - 01/2008
2	Lung Neoplasms (Lung Cancer) 05/2013 - 01/2012
2	Breast Neoplasms (Breast Cancer) 02/2012 - 11/2010
2	Neoplasms, Cystic, Mucinous, and Serous 01/2012 - 08/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2009 - 01/2004
2	Hypoxia (Hypoxemia) 10/2008 - 01/2004
2	Prostatic Neoplasms (Prostate Cancer) 01/2008 - 02/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2006 - 05/2006
2	Metaplasia 05/2003 - 04/2003
1	Inflammation (Inflammations) 01/2023
1	Edema (Dropsy) 01/2023
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 01/2023
1	Bites and Stings (Sting) 01/2023

Drug/Important Bio-Agent (IBA)

39	Calcibiotic Root Canal SealerIBA 03/2024 - 12/2009
19	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2006
15	Biomarkers (Surrogate Marker)IBA 03/2024 - 09/2002
11	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2004
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2019 - 06/2011
9	MucinsIBA 07/2020 - 02/2002
7	hydrogen sulfite (bisulfite)IBA 01/2022 - 07/2003
5	Fluorouracil (Carac)FDA LinkGeneric 10/2023 - 04/2013
4	Cadherins (E-Cadherin)IBA 01/2020 - 09/2002
4	ParaffinIBA 01/2019 - 05/2004
4	EnzymesIBA 12/2017 - 01/2005
4	Indicators and Reagents (Reagents)IBA 05/2017 - 01/2006
4	Leucovorin (Folinic Acid)FDA Link 01/2016 - 04/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 09/2007
3	Circulating Tumor DNAIBA 07/2023 - 01/2020
3	regorafenibIBA 07/2023 - 01/2015
3	B7-H1 AntigenIBA 01/2023 - 12/2017
3	Transaminases (Aminotransferases)IBA 01/2023 - 10/2009
3	ElementsIBA 12/2022 - 10/2009
3	Messenger RNA (mRNA)IBA 03/2022 - 01/2017
3	Phosphotransferases (Kinase)IBA 12/2021 - 10/2006
3	Formaldehyde (Formol)FDA Link 01/2019 - 05/2004
3	Phenobarbital (Luminal)FDA Link 05/2017 - 02/2012
3	Small Interfering RNA (siRNA)IBA 11/2015 - 08/2008
3	AnnexinsIBA 09/2015 - 11/2014
3	antineoplaston A10 (A 10)IBA 09/2015 - 11/2014
2	Dextran SulfateIBA 01/2023 - 01/2020
2	InterferonsIBA 01/2023 - 01/2005
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 08/2011
2	Immune Checkpoint InhibitorsIBA 12/2022 - 09/2020
2	Cell-Free Nucleic AcidsIBA 12/2020 - 01/2020
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 04/2013
2	LigandsIBA 09/2018 - 05/2018
2	RNA (Ribonucleic Acid)IBA 01/2017 - 05/2004
2	CateninsIBA 01/2017 - 08/2014
2	Epithelial Cell Adhesion MoleculeIBA 03/2016 - 08/2014
2	LipidsIBA 07/2013 - 10/2009
2	UbiquitinIBA 05/2013 - 10/2008
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2013 - 10/2008
2	Decitabine FDA Link 06/2012 - 08/2008
2	trichostatin A (A 300)IBA 06/2012 - 08/2008
2	Estrogen ReceptorsIBA 11/2010 - 10/2007
2	Tumor Biomarkers (Tumor Markers)IBA 02/2009 - 06/2007
2	Carcinoembryonic AntigenIBA 10/2007 - 02/2002
2	Death-Associated Protein KinasesIBA 07/2004 - 09/2002
2	poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA 05/2003 - 04/2003
1	Liver GlycogenIBA 01/2023
1	SolutionsIBA 01/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023
1	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 01/2023
1	Sucrose (Saccharose)IBA 01/2023

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 10/2023 - 08/2011
11	Therapeutics 12/2022 - 01/2005
9	Adjuvant Chemotherapy 01/2023 - 08/2011
6	Chemoradiotherapy 01/2021 - 08/2011
4	Neoadjuvant Therapy 01/2021 - 01/2014
3	Immunotherapy 10/2023 - 01/2016
2	Radiotherapy 11/2018 - 08/2010
2	Combination Drug Therapy (Combination Chemotherapy) 06/2011 - 12/2010
1	Fecal Microbiota Transplantation 01/2023